Search Results Search Sort by RelevanceMost Recent Case and Commentary Mar 2019 What Should Be the Scope of a Health Network’s Obligation to Respond After a Hospital Closure? George M. Holmes, PhD and Sharita R. Thomas, MPP Since clinics are economic hubs in some communities, consequences of a clinic closing or moving are numerous. AMA J Ethics. 2019;21(3):E215-222. doi: 10.1001/amajethics.2019.215. Case and Commentary Apr 2019 Should a Psychiatrist Prescribe a Nanodrug to Help Parents Monitor a Teen’s Adherence? Constance E. George, MD, MA Ethical stakes include a psychiatrist’s care management responsibilities and burdens borne by family members over the course of the patient’s care. AMA J Ethics. 2019;21(4):E317-323. doi: 10.1001/amajethics.2019.317. Case and Commentary Apr 2019 Should Trackable Pill Technologies Be Used to Facilitate Adherence Among Patients Without Insight? Tahir Rahman, MD A form of aripiprazole places unique ethical and clinical demands on mental health professionals. AMA J Ethics. 2019;21(4):E332-336. doi: 10.1001/amajethics.2019.332. Policy Forum Jul 2016 Protecting Pharmaceutical Patents and Test Data: How the Trans-Pacific Partnership Agreement Could Affect Access to Medicines in the US and Abroad Jing Luo, MD and Aaron S. Kesselheim, MD, JD, MPH The Trans-Pacific Partnership Agreement could affect low-income patients’ access to medicines in signatory countries by reducing generic competition. AMA J Ethics. 2016;18(7):727-735. doi: 10.1001/journalofethics.2016.18.7.pfor1-1607. Medicine and Society May 2019 How Should Mechanical Circulatory Support Be Deactivated for Patients With Depression at the End of Life? Stephan R. Weinland, PhD, MS and James Levenson, MD End-stage heart failure patients can experience depression along with their chronic illness. Multidisciplinary responses are critical. AMA J Ethics. 2019;21(5):E429-434. doi: 10.1001/amajethics.2019.429. Case and Commentary May 2019 How Should Physicians Respond to Requests for LVAD Removal? Larry A. Allen, MD, MHS Patients have a right to decline or withdraw LVADs. Informed consent and shared decision making is not easy, however, with treatments that are high risk, high reward. AMA J Ethics. 2019;21(5):E394-400. doi: 10.1001/amajethics.2019.394. Case and Commentary Apr 2016 Is Proxy Consent for an Invasive Procedure on a Patient with Intellectual Disabilities Ethically Sufficient? Commentary 1 Stephen Corey, MD and Peter Bulova, MD Women with intellectual disabilities should not be sedated for a pap smear without their assent, and the test’s risks and benefits should be weighed. AMA J Ethics. 2016;18(4):373-378. doi: 10.1001/journalofethics.2016.18.4.ecas3-1604. Case and Commentary Apr 2016 Is Proxy Consent for an Invasive Procedure on a Patient with Intellectual Disabilities Ethically Sufficient? Commentary 2 Sonya Charles, PhD Women with intellectual disabilities should not be sedated for a pap smear without their assent, and the test’s risks and benefits should be weighed. AMA J Ethics. 2016;18(4):379-383. doi: 10.1001/journalofethics.2016.18.4.ecas3-1604. Case and Commentary Jul 2019 How Should Clinicians Navigate Decision Making for Unrepresented Patients? Timothy M. Dempsey, MD, MPH and Erin Sullivan DeMartino, MD A deliberative approach to responding to needs and vulnerabilities of unrepresented patients can help make the most of having too little information. AMA J Ethics. 2019;21(7):E559-565. doi: 10.1001/amajethics.2019.559. Health Law Jul 2019 Regional Unrepresented Patient Advocacy Committee as an Alternative for Decision Making Lisa K. Anderson-Shaw, DrPH, MA, MSN, ANP-BC A UPAC is an alternative to engaging a guardianship court appointment process or to using physicians or ethics committees as decision makers. AMA J Ethics. 2019;21(7):E594-599. doi: 10.1001/amajethics.2019.594. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary Mar 2019 What Should Be the Scope of a Health Network’s Obligation to Respond After a Hospital Closure? George M. Holmes, PhD and Sharita R. Thomas, MPP Since clinics are economic hubs in some communities, consequences of a clinic closing or moving are numerous. AMA J Ethics. 2019;21(3):E215-222. doi: 10.1001/amajethics.2019.215.
Case and Commentary Apr 2019 Should a Psychiatrist Prescribe a Nanodrug to Help Parents Monitor a Teen’s Adherence? Constance E. George, MD, MA Ethical stakes include a psychiatrist’s care management responsibilities and burdens borne by family members over the course of the patient’s care. AMA J Ethics. 2019;21(4):E317-323. doi: 10.1001/amajethics.2019.317.
Case and Commentary Apr 2019 Should Trackable Pill Technologies Be Used to Facilitate Adherence Among Patients Without Insight? Tahir Rahman, MD A form of aripiprazole places unique ethical and clinical demands on mental health professionals. AMA J Ethics. 2019;21(4):E332-336. doi: 10.1001/amajethics.2019.332.
Policy Forum Jul 2016 Protecting Pharmaceutical Patents and Test Data: How the Trans-Pacific Partnership Agreement Could Affect Access to Medicines in the US and Abroad Jing Luo, MD and Aaron S. Kesselheim, MD, JD, MPH The Trans-Pacific Partnership Agreement could affect low-income patients’ access to medicines in signatory countries by reducing generic competition. AMA J Ethics. 2016;18(7):727-735. doi: 10.1001/journalofethics.2016.18.7.pfor1-1607.
Medicine and Society May 2019 How Should Mechanical Circulatory Support Be Deactivated for Patients With Depression at the End of Life? Stephan R. Weinland, PhD, MS and James Levenson, MD End-stage heart failure patients can experience depression along with their chronic illness. Multidisciplinary responses are critical. AMA J Ethics. 2019;21(5):E429-434. doi: 10.1001/amajethics.2019.429.
Case and Commentary May 2019 How Should Physicians Respond to Requests for LVAD Removal? Larry A. Allen, MD, MHS Patients have a right to decline or withdraw LVADs. Informed consent and shared decision making is not easy, however, with treatments that are high risk, high reward. AMA J Ethics. 2019;21(5):E394-400. doi: 10.1001/amajethics.2019.394.
Case and Commentary Apr 2016 Is Proxy Consent for an Invasive Procedure on a Patient with Intellectual Disabilities Ethically Sufficient? Commentary 1 Stephen Corey, MD and Peter Bulova, MD Women with intellectual disabilities should not be sedated for a pap smear without their assent, and the test’s risks and benefits should be weighed. AMA J Ethics. 2016;18(4):373-378. doi: 10.1001/journalofethics.2016.18.4.ecas3-1604.
Case and Commentary Apr 2016 Is Proxy Consent for an Invasive Procedure on a Patient with Intellectual Disabilities Ethically Sufficient? Commentary 2 Sonya Charles, PhD Women with intellectual disabilities should not be sedated for a pap smear without their assent, and the test’s risks and benefits should be weighed. AMA J Ethics. 2016;18(4):379-383. doi: 10.1001/journalofethics.2016.18.4.ecas3-1604.
Case and Commentary Jul 2019 How Should Clinicians Navigate Decision Making for Unrepresented Patients? Timothy M. Dempsey, MD, MPH and Erin Sullivan DeMartino, MD A deliberative approach to responding to needs and vulnerabilities of unrepresented patients can help make the most of having too little information. AMA J Ethics. 2019;21(7):E559-565. doi: 10.1001/amajethics.2019.559.
Health Law Jul 2019 Regional Unrepresented Patient Advocacy Committee as an Alternative for Decision Making Lisa K. Anderson-Shaw, DrPH, MA, MSN, ANP-BC A UPAC is an alternative to engaging a guardianship court appointment process or to using physicians or ethics committees as decision makers. AMA J Ethics. 2019;21(7):E594-599. doi: 10.1001/amajethics.2019.594.